Pharmacokinetics and Pharmacodynamic of Alpelisib
2023 · Clinical Pharmacokinetics · 9 citations
https://doi.org/10.1007/s40262-022-01195-2
A
Antonin Schmitt
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
74
Papers
884
Citations
16
h-index
23
i10-index
Antonin Schmitt is an academic researcher from Inserm. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Colorectal Cancer Treatments and Studies & Neutropenia and Cancer Infections. The author has an h-index of 16, co-authored 63 publications.
ORCID: 0000-0002-3132-7730Papers by this author
worksTrastuzumab-emtansine induced pleural and pericardial effusions
2021 · Journal of Oncology Pharmacy Practice · 7 citations
https://doi.org/10.1177/10781552211015772
Smartphone-based application and nurses’ interventions for symptoms monitoring in patients treated with oral anticancer agents: A 1-year follow-up in a tertiary cancer center
2022 · Journal of Oncology Pharmacy Practice · 3 citations
https://doi.org/10.1177/10781552221117731
Safety and efficacy of trifluridine/tipiracil +/− bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial
2025 · Signal Transduction and Targeted Therapy · 2 citations
https://doi.org/10.1038/s41392-024-02116-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat